ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 256

Muckle-Wells Syndrome in Chinese Adult Patients

Di Wu, Min Shen and Xiaofeng Zeng, Rheumatology, Peking Union Medical College Hospital, Beijing, China

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Muckle-Wells syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: Miscellaneous Rheumatic and Inflammatory Diseases - Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Muckle-Wells syndrome (MWS) is a rare autoinflammatory disease, which is categorized as one of the three cryopyrin-associated periodic syndromes (CAPS). MWS is characterized by recurrent episodes of fever, rash and joint pain, and may lead to renal amyloidosis and severe neurological involvements such as hydrocephalus and progressive hearing loss. Here we describe the first cohort of MWS patients in Chinese population, with emphasis on clinical features and gene variations.

Methods: Four Han Chinese patients were diagnosed as MWS from the year 2013 to 2016 at our adult clinic for autoinflammatory diseases. All the diagnoses were confirmed by mutations in the NLRP3 gene. All relevant clinical and genetic data were collected retrospectively and followed up prospectively.

Results: All the four patients were male. The median age at disease onset was 4.5 (ranging from 2 to 46) years and the mean disease duration before diagnosis was 14.25¡À12.63 (ranging from 1 to 29) years. One patient had adult onset disease at the age of 46, and the remaining patients experienced delayed diagnosis into adulthood because of physicians’ unfamiliarity with this syndrome in China. All patients denied positive family history. All patients had intermittent febrile episodes with moderate to high temperature. One patient’s attacks could be triggered by cold exposure. The mean duration of fever attacks was 3.81¡À2.51 (ranging from 0.25 to 6) days and the interval between attacks ranged from several weeks to several months. Skin rashes were present in all patients, which could be erythematous macular or papular, urticarial, erythema nodosa-like and Sweet disease-like. Two out of 4 suffered from frequent oral ulcers, 2/4 conjunctivitis, 2/4 myalgia, 2/4 headache, 2/4 arthralgia, 1/4 prominent polyarthritis, 1/4 pharingitis, 1/4 abdominal pain, 1/4 severe sensorineural hearing loss, 1/4 epilepsy, 1/4 chronic meningitis with communicating hydrocephalus. All patients had moderately elevated peripheral leukocyte count and systemic inflammatory markers during attacks, which return to normal during intervals. Each patient carried a novel heterozygous mutation in NLRP3 gene, including Q705K, V72M, D31V, T350M, respectively. Three patients had good response to the combination of moderate to high dose of prednisone and conventional DMARDs. Due to economic constraints and unavailability of anti-interleukin 1 therapies in China, only one patient received an anti-TNF¦Áagent. None showed evidence of renal amyloidosis.

Conclusion: Our observational study suggests for the first time that MWS could be identified among adult Chinese patients with intermittent fever of unknown cause, but with unique features compared with previously reported patient cohorts. Our patients are exclusively male without positive family history, with fewer presentations of urticarial rash and hearing loss, and responded better to conventional oral treatments. Considering the lack of amyloidosis, whether our patients had better outcome remains to be seen. The more accurate characterization of Chinese patients suffering from MWS and CAPS needs further studies. Figure 1. A1& A2: erythematous macular and oral ulcer of one patient. B1& B2: resolution of transient arthritis in 1st TMP within one day. C1& C2: new maculopapular rash in the neck and pigmentation after rash disappearance in the forearm.

sign.jpg


Disclosure: D. Wu, None; M. Shen, None; X. Zeng, None.

To cite this abstract in AMA style:

Wu D, Shen M, Zeng X. Muckle-Wells Syndrome in Chinese Adult Patients [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/muckle-wells-syndrome-in-chinese-adult-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/muckle-wells-syndrome-in-chinese-adult-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology